182 related articles for article (PubMed ID: 10329853)
21. Intraepithelial NK cell-derived IL-13 induces intestinal pathology associated with nematode infection.
McDermott JR; Humphreys NE; Forman SP; Donaldson DD; Grencis RK
J Immunol; 2005 Sep; 175(5):3207-13. PubMed ID: 16116211
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-13's key role in asthma shown.
Vogel G
Science; 1998 Dec; 282(5397):2168. PubMed ID: 9890820
[No Abstract] [Full Text] [Related]
23. IL-4/IL-13 signaling beyond JAK/STAT.
Jiang H; Harris MB; Rothman P
J Allergy Clin Immunol; 2000 Jun; 105(6 Pt 1):1063-70. PubMed ID: 10856136
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-4 and interleukin-13: their similarities and discrepancies.
Chomarat P; Banchereau J
Int Rev Immunol; 1998; 17(1-4):1-52. PubMed ID: 9914942
[TBL] [Abstract][Full Text] [Related]
25. An interleukin 4 (IL-4) mutant protein inhibits both IL-4 or IL-13-induced human immunoglobulin G4 (IgG4) and IgE synthesis and B cell proliferation: support for a common component shared by IL-4 and IL-13 receptors.
Aversa G; Punnonen J; Cocks BG; de Waal Malefyt R; Vega F; Zurawski SM; Zurawski G; de Vries JE
J Exp Med; 1993 Dec; 178(6):2213-8. PubMed ID: 7504061
[TBL] [Abstract][Full Text] [Related]
26. Specific antagonism of type I IL-4 receptor with a mutated form of murine IL-4.
Schnare M; Blum H; Jüttner S; Röllinghoff M; Gessner A
J Immunol; 1998 Oct; 161(7):3484-92. PubMed ID: 9759868
[TBL] [Abstract][Full Text] [Related]
27. Distinct roles for IL-13 and IL-4 via IL-13 receptor alpha1 and the type II IL-4 receptor in asthma pathogenesis.
Munitz A; Brandt EB; Mingler M; Finkelman FD; Rothenberg ME
Proc Natl Acad Sci U S A; 2008 May; 105(20):7240-5. PubMed ID: 18480254
[TBL] [Abstract][Full Text] [Related]
28. Interleukin (IL) 4 and IL-13 act on human lung fibroblasts. Implication in asthma.
Doucet C; Brouty-Boyé D; Pottin-Clémenceau C; Canonica GW; Jasmin C; Azzarone B
J Clin Invest; 1998 May; 101(10):2129-39. PubMed ID: 9593769
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-13: characterization and biologic properties.
McKenzie AN; Zurawski G
Cancer Treat Res; 1995; 80():367-78. PubMed ID: 8821586
[No Abstract] [Full Text] [Related]
30. An antagonistic IL-4 mutant prevents type I allergy in the mouse: inhibition of the IL-4/IL-13 receptor system completely abrogates humoral immune response to allergen and development of allergic symptoms in vivo.
Grunewald SM; Werthmann A; Schnarr B; Klein CE; Bröcker EB; Mohrs M; Brombacher F; Sebald W; Duschl A
J Immunol; 1998 Apr; 160(8):4004-9. PubMed ID: 9558109
[TBL] [Abstract][Full Text] [Related]
31. Signal transduction via the interleukin-4 receptor and its correlation with atopy.
Izuhara K; Shirakawa T
Int J Mol Med; 1999 Jan; 3(1):3-10. PubMed ID: 9864378
[TBL] [Abstract][Full Text] [Related]
32. Interleukin (IL)-13 and IL-4 inhibit proliferation and stimulate IL-6 formation in human osteoblasts: evidence for involvement of receptor subunits IL-13R, IL-13Ralpha, and IL-4Ralpha.
Frost A; Jonsson KB; Brändström H; Ljunghall S; Nilsson O; Ljunggren O
Bone; 2001 Mar; 28(3):268-74. PubMed ID: 11248656
[TBL] [Abstract][Full Text] [Related]
33. Upon prolonged allergen exposure IL-4 and IL-4Ralpha knockout mice produce specific IgE leading to anaphylaxis.
Grunewald SM; Teufel M; Erb K; Nelde A; Mohrs M; Brombacher F; Bröcker EB; Sebald W; Duschl A
Int Arch Allergy Immunol; 2001 Aug; 125(4):322-8. PubMed ID: 11574754
[TBL] [Abstract][Full Text] [Related]
34. Peptide-induced anergy in allergen-specific human Th2 cells results in lack of cytokine production and B cell help for IgE synthesis. Reversal by IL-2, not by IL-4 or IL-13.
Fasler S; Aversa G; Terr A; Thestrup-Pedersen K; de Vries JE; Yssel H
J Immunol; 1995 Nov; 155(9):4199-206. PubMed ID: 7594575
[TBL] [Abstract][Full Text] [Related]
35. Tryptanthrin inhibits Th2 development, and IgE-mediated degranulation and IL-4 production by rat basophilic leukemia RBL-2H3 cells.
Iwaki K; Ohashi E; Arai N; Kohno K; Ushio S; Taniguchi M; Fukuda S
J Ethnopharmacol; 2011 Mar; 134(2):450-9. PubMed ID: 21216280
[TBL] [Abstract][Full Text] [Related]
36. Interleukins-4, -5, and -13: emerging therapeutic targets in allergic disease.
Foster PS; Martinez-Moczygemba M; Huston DP; Corry DB
Pharmacol Ther; 2002 Jun; 94(3):253-64. PubMed ID: 12113801
[TBL] [Abstract][Full Text] [Related]
37. IL-13 is a key regulatory cytokine for Th2 cell-mediated pulmonary granuloma formation and IgE responses induced by Schistosoma mansoni eggs.
Chiaramonte MG; Schopf LR; Neben TY; Cheever AW; Donaldson DD; Wynn TA
J Immunol; 1999 Jan; 162(2):920-30. PubMed ID: 9916716
[TBL] [Abstract][Full Text] [Related]
38. Differences between IL-4- and IL-4 receptor alpha-deficient mice in chronic leishmaniasis reveal a protective role for IL-13 receptor signaling.
Mohrs M; Ledermann B; Köhler G; Dorfmüller A; Gessner A; Brombacher F
J Immunol; 1999 Jun; 162(12):7302-8. PubMed ID: 10358179
[TBL] [Abstract][Full Text] [Related]
39. The interleukin 13 receptor complex.
Jensen PL
Stem Cells; 2000; 18(1):61-2. PubMed ID: 10661573
[No Abstract] [Full Text] [Related]
40. IL-4 and IL-13 up-regulate intestinal trefoil factor expression: requirement for STAT6 and de novo protein synthesis.
Blanchard C; Durual S; Estienne M; Bouzakri K; Heim MH; Blin N; Cuber JC
J Immunol; 2004 Mar; 172(6):3775-83. PubMed ID: 15004182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
